genomic profiling of hr /her2- breast cancer and brain metastases
Published 3 months ago • 104 plays • Length 3:10Download video MP4
Download video MP3
Similar videos
-
1:22
genomic profiling in her2 disease
-
1:35
gene expression profiling of breast cancer brain mets shows enrichment for non-luminal subtypes
-
1:05
the genomic characterization of primary and metastatic her2-low breast cancers
-
3:15
brain metastases in her2 breast cancer
-
1:26
genomic and transcriptomic landscape of her2-low breast cancer
-
2:14
survival in premenopausal hr /her2- breast cancer with micro-metastasis and 21-gene score
-
0:53
the latest news on the management of breast cancer patients with brain metastases
-
0:53
tuxedo-1: t-dxd for patients with her2-positive breast cancer and brain metastasis
-
2:09
the evolution of her2 targeting in metastatic breast breast cancer
-
5:37
therapeutic landscape for patients with her2-positive breast cancer with active brain metastases
-
2:11
her2 in prognosis of brain metastasis in breast cancer
-
2:33
her2climb: tucatinib with trastuzumab and capecitabine for her2 breast cancer with brain metastases
-
1:45
the comprehensive genomic characterization of her2-low breast cancer
-
1:24
potential treatment approaches for breast cancer with brain metastases
-
1:11
her2climb: tucatinib efficacious against brain metastases in patients with her2 breast cancer
-
2:08
recent progress in managing brain metastasis in breast cancer
-
0:35
key challenge associated with the management of hr /her2- breast cancer
-
1:56
treating her2 breast cancer with brain metastases
-
1:29
tuxedo-1: trastuzumab deruxtecan for the treatment of her2-positive breast cancer brain metastases